• skillissuer@discuss.tchncs.de
      link
      fedilink
      arrow-up
      7
      ·
      1 year ago

      i don’t think so, if the model is owned by single company, trained on their own dataset, access is restricted and basically used as an internal tool, that would make that company sole owners of all generated content right? that’s what happened with chematica, this is used for synthesis planning at merck so mildly similar area

      • ag_roberston_author@beehaw.org
        link
        fedilink
        English
        arrow-up
        5
        ·
        1 year ago

        Well that’s not how it works with AI generated text or images. OpenAI can’t copyright anything ChatGPT produces no more than anyone else can.

    • Hirom@beehaw.org
      link
      fedilink
      arrow-up
      4
      ·
      1 year ago

      The article gives a hint, by explaining AI does only part of the work.

      AI systems cannot yet accomplish every part of the drug development process alone, particularly in the late stages.